DHVI receives $15 million from NC state legislature to develop preventive vaccines against SARS-CoV-2
The State of North Carolina enacted Session Law 2020-4, an Act to Provide Aid to North Carolinians in Response to the Coronavirus Disease 2019 Crisis, also known as the 2020 COVID-19 Recovery Act. This law directs $15,000,000 in funding to the Duke Human Vaccine Institute (DHVI) to “develop a safe and effective COVID-19 vaccine that will be available to the public as soon as possible.”
Dr. Barton Haynes, Director of the Duke Human Vaccine Institute will lead of team of Investigators in developing two types of preventive vaccines: a passive vaccine and an active vaccine. DHVI Investigators in this project are Drs. Kevin Saunders, Tom Denny, Chris Woods, Rory Henderson, Kevin Wiehe, Matt Johnson, Greg Sempowski and Amy Caparoni.
Both preventative vaccines will provide protection against SARS-CoV-2, the virus that causes COVID-19.